Alveotechnologies
<UNKNOWN> · 1 known investors
Alveo Technologies develops a portable molecular testing platform that delivers rapid pathogen detection in under one hour at the point of need, with initial focus on avian influenza testing for poultry farms and agricultural operations. The platform combines palm-sized analyzers and preloaded cartridges to enable on-site detection, traceability, and results delivered via smartphone.
AgTechHealthtechMedical Devices